Tapewire

Nasdaq · USD

HQY

HEALTHEQUITY, INC.

Export transactions ↓
Tapewire entity
3639
SEC CIK
0001428336
Parsed reports
607

Last 12 months

Inside the activity.

0 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202503
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202603
Jun 202600
Jul 202602
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 01, 2017 Filed Aug 2, 2017 22:16 UTC Exercise / conversionCommon Stock 15,000 $14.00 $210,000.00
Disclosure

SEC source: 0001140361-17-029923 · doc1.xml · nonDerivative · entry 3

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2017 Filed Aug 2, 2017 22:16 UTC Exercise / conversionCommon Stock 15,000 $25.39 $380,850.00
Disclosure

SEC source: 0001140361-17-029923 · doc1.xml · nonDerivative · entry 2

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2017 Filed Aug 2, 2017 22:16 UTC Exercise / conversionCommon Stock 15,000 $21.27 $319,050.00
Disclosure

SEC source: 0001140361-17-029923 · doc1.xml · nonDerivative · entry 1

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,862

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 01, 2017 Filed Sep 20, 2017 01:16 UTC GrantStock Option (right to buy) · Derivative 7,736 $0.00 Strike: $47.21 $0.00
Disclosure

SEC source: 0001140361-17-035981 · doc1.xml · derivative · entry 2

Wellborn Gayle Furgurson · CIK 0001712960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,736

Underlying: Common Stock · 7,736 shares

Expires 2027-08-01

F1 · derivative.exercise_date: The option becomes exercisable as to 2,439 shares on January 31, 2018. The option becomes exercisable as to the remaining 5,297 shares in three equal annual installments on August 1, 2018, 2019 and 2020.

Read SEC document
August 01, 2017 Filed Sep 20, 2017 01:16 UTC GrantCommon Stock 2,644 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-035981 · doc1.xml · nonDerivative · entry 1

Wellborn Gayle Furgurson · CIK 0001712960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,644

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionStock Option (right to buy) · Derivative 1 $0.00 Strike: $25.39 $0.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · derivative · entry 13

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2025-03-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionStock Option (right to buy) · Derivative 1 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · derivative · entry 12

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionStock Option (right to buy) · Derivative 1 $0.00 Strike: $1.50 $0.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · derivative · entry 11

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2023-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionStock Option (right to buy) · Derivative 1 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · derivative · entry 10

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2022-04-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionStock Option (right to buy) · Derivative 1 $0.00 Strike: $1.25 $0.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · derivative · entry 9

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2021-10-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionStock Option (right to buy) · Derivative 1 $0.00 Strike: $21.27 $0.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · derivative · entry 8

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2026-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 15,000 $25.39 $380,850.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · nonDerivative · entry 6

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 15,000 $14.00 $210,000.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · nonDerivative · entry 5

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 15,000 $1.50 $22,500.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · nonDerivative · entry 4

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 15,000 $1.25 $18,750.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · nonDerivative · entry 3

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 7,500 $1.25 $9,375.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · nonDerivative · entry 2

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 31, 2017 Filed Aug 2, 2017 22:26 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 15,000 $21.27 $319,050.00
Disclosure

SEC source: 0001140361-17-029928 · doc1.xml · nonDerivative · entry 1

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 17, 2017 Filed Jul 20, 2017 01:21 UTC
Neeleman StephenDirector · Founder and Vice Chairman
Exercise / conversionStock Option (right to buy) · Derivative 1,000 $0.00 Strike: $14.00 $0.00
Disclosure

SEC source: 0001140361-17-028227 · doc1.xml · derivative · entry 6

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 1,000 shares

Expires 2024-07-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F10 · derivative.exercise_date: The option is immediately exercisable.

Read SEC document
July 17, 2017 Filed Jul 20, 2017 01:21 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 200 $51.26 $10,252.00
Disclosure

SEC source: 0001140361-17-028227 · doc1.xml · nonDerivative · entry 5

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 263,000

F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.25 to $51.27, inclusive.

F8 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Read SEC document
July 17, 2017 Filed Jul 20, 2017 01:21 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 4,800 $50.83 $243,973.92
Disclosure

SEC source: 0001140361-17-028227 · doc1.xml · nonDerivative · entry 4

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 263,200

F6 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company, on December 13, 2016.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.23 to $51.22, inclusive.

F8 · ownership.nature: Shares held of record by Family Holdings. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.

Read SEC document
July 17, 2017 Filed Jul 20, 2017 01:21 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 2,500 $50.82 $127,056.25
Disclosure

SEC source: 0001140361-17-028227 · doc1.xml · nonDerivative · entry 3

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 745,285

F3 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Stephen and Christine Neeleman Trust on December 13, 2016.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.26 to $51.15, inclusive.

F5 · ownership.nature: Shares held of record by the Stephen and Christine Neeleman Trust.

Read SEC document
July 17, 2017 Filed Jul 20, 2017 01:21 UTC
Neeleman StephenDirector · Founder and Vice Chairman
SaleCommon Stock 1,000 $50.76 $50,761.60
Disclosure

SEC source: 0001140361-17-028227 · doc1.xml · nonDerivative · entry 2

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.26 to $51.16, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (7) and (9) to this Form 4.

Read SEC document
July 17, 2017 Filed Jul 20, 2017 01:21 UTC
Neeleman StephenDirector · Founder and Vice Chairman
Exercise / conversionCommon Stock 1,000 $14.00 $14,000.00
Disclosure

SEC source: 0001140361-17-028227 · doc1.xml · nonDerivative · entry 1

Neeleman Stephen · CIK 0001614838 · Director · Founder and Vice Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2016.

Read SEC document
July 14, 2017 Filed Jul 15, 2017 01:46 UTC
Medici FrankDirector
SaleCommon Stock 72,791 $51.41 $3,742,112.52
Disclosure

SEC source: 0001140361-17-027915 · doc1.xml · nonDerivative · entry 3

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,346,177

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.40 to $51.50, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
July 14, 2017 Filed Jul 15, 2017 01:42 UTC SaleCommon Stock 72,791 $51.41 $3,742,112.52
Disclosure

SEC source: 0001140361-17-027914 · doc1.xml · nonDerivative · entry 3

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,346,177

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.40 to $51.50, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
July 13, 2017 Filed Jul 15, 2017 01:46 UTC
Medici FrankDirector
SaleCommon Stock 131,800 $51.42 $6,777,156.00
Disclosure

SEC source: 0001140361-17-027915 · doc1.xml · nonDerivative · entry 2

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,418,968

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.24 to $51.52, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
July 13, 2017 Filed Jul 15, 2017 01:42 UTC SaleCommon Stock 131,800 $51.42 $6,777,156.00
Disclosure

SEC source: 0001140361-17-027914 · doc1.xml · nonDerivative · entry 2

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,418,968

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.24 to $51.52, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
July 12, 2017 Filed Jul 15, 2017 01:46 UTC
Medici FrankDirector
SaleCommon Stock 332,511 $51.13 $16,999,624.88
Disclosure

SEC source: 0001140361-17-027915 · doc1.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,550,768

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
July 12, 2017 Filed Jul 15, 2017 01:42 UTC SaleCommon Stock 332,511 $51.13 $16,999,624.88
Disclosure

SEC source: 0001140361-17-027914 · doc1.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,550,768

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.00 to $51.42, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
July 07, 2017 Filed Jul 8, 2017 00:37 UTC
Medici FrankDirector
SaleCommon Stock 186,749 $50.26 $9,386,564.99
Disclosure

SEC source: 0001104659-17-044148 · a4.xml · nonDerivative · entry 2

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,883,279

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.10 to $50.32, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
July 07, 2017 Filed Jul 8, 2017 00:36 UTC SaleCommon Stock 186,749 $50.26 $9,386,564.99
Disclosure

SEC source: 0001104659-17-044147 · a4.xml · nonDerivative · entry 2

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 7,883,279

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.10 to $50.32, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
July 05, 2017 Filed Jul 8, 2017 00:37 UTC
Medici FrankDirector
SaleCommon Stock 23,649 $50.27 $1,188,906.18
Disclosure

SEC source: 0001104659-17-044148 · a4.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,070,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.21 to $50.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
July 05, 2017 Filed Jul 8, 2017 00:36 UTC SaleCommon Stock 23,649 $50.27 $1,188,906.18
Disclosure

SEC source: 0001104659-17-044147 · a4.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,070,028

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.21 to $50.51, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 29, 2017 Filed Jul 4, 2017 00:17 UTC
Rana Manu SDirector
Exercise / conversionRestricted Stock Unit · Derivative 795 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-043280 · a4.xml · derivative · entry 5

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 795 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F4 · derivative.exercise_date: The restricted stock units are fully vested.

F4 · derivative.expiration_date: The restricted stock units are fully vested.

Read SEC document
June 29, 2017 Filed Jul 4, 2017 00:17 UTC
Rana Manu SDirector
Exercise / conversionRestricted Stock Units · Derivative 430 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-043280 · a4.xml · derivative · entry 2

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 430 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vested as to 215 shares on each of February 1, 2017 and May 1, 2017.

F2 · derivative.expiration_date: The restricted stock units vested as to 215 shares on each of February 1, 2017 and May 1, 2017.

Read SEC document
June 29, 2017 Filed Jul 4, 2017 00:17 UTC
Rana Manu SDirector
Exercise / conversionCommon Stock 1,225 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-17-043280 · a4.xml · nonDerivative · entry 1

Rana Manu S · CIK 0001352786 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,225

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Read SEC document
June 26, 2017 Filed Jun 28, 2017 00:26 UTC SaleCommon Stock 1,100 $52.29 $57,517.46
Disclosure

SEC source: 0001140361-17-026329 · doc1.xml · nonDerivative · entry 2

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,093,677

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.03 to $52.50, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 26, 2017 Filed Jun 27, 2017 23:46 UTC
Medici FrankDirector
SaleCommon Stock 1,100 $52.29 $57,517.46
Disclosure

SEC source: 0001140361-17-026326 · doc1.xml · nonDerivative · entry 2

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,093,677

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.03 to $52.50, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 26, 2017 Filed Jun 29, 2017 01:40 UTC GrantCommon Stock 430 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-026543 · doc1.xml · nonDerivative · entry 1

LEAVITT MICHAEL O · CIK 0001536118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,862

F1 · balance_after: Includes 217 shares underlying restricted stock units previously reported in Table II.

Read SEC document
June 26, 2017 Filed Jun 29, 2017 01:37 UTC GrantCommon Stock 3,556 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-026542 · doc1.xml · nonDerivative · entry 1

Dilsaver Evelyn S · CIK 0001391387 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

F1 · balance_after: Includes 1,778 shares underlying restricted stock units previously reported on Table II.

Read SEC document
June 23, 2017 Filed Jun 28, 2017 00:26 UTC SaleCommon Stock 54,967 $51.78 $2,846,108.81
Disclosure

SEC source: 0001140361-17-026329 · doc1.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,094,777

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $52.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 23, 2017 Filed Jun 27, 2017 23:46 UTC
Medici FrankDirector
SaleCommon Stock 54,967 $51.78 $2,846,108.81
Disclosure

SEC source: 0001140361-17-026326 · doc1.xml · nonDerivative · entry 1

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,094,777

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.75 to $52.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 22, 2017 Filed Jun 26, 2017 20:37 UTC GrantCommon Stock 1,778 $0.00 $0.00
Disclosure

SEC source: 0001140361-17-026094 · doc1.xml · nonDerivative · entry 1

Corvino Frank · CIK 0001614878 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,556

F1 · balance_after: Includes 1,778 shares underlying restricted stock units previously reported in Table II.

Read SEC document
June 21, 2017 Filed Jun 21, 2017 22:37 UTC SaleCommon Stock 129,263 $51.95 $6,714,682.87
Disclosure

SEC source: 0001140361-17-025728 · doc1.xml · nonDerivative · entry 3

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,149,744

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.18, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 21, 2017 Filed Jun 21, 2017 22:35 UTC
Medici FrankDirector
SaleCommon Stock 129,263 $51.95 $6,714,682.87
Disclosure

SEC source: 0001140361-17-025727 · doc1.xml · nonDerivative · entry 3

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,149,744

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.80 to $52.18, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 21, 2017 Filed Jun 24, 2017 01:35 UTC
Otten William RobertExecutive VP of Sales
GrantStock Option (right to buy) · Derivative 43,000 $0.00 Strike: $51.44 $0.00
Disclosure

SEC source: 0001104659-17-041359 · a4.xml · derivative · entry 2

Otten William Robert · CIK 0001704840 · Executive VP of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,000

Underlying: Common Stock · 43,000 shares

Expires 2027-06-21

F1 · derivative.exercise_date: The option becomes exercisable in four equal annual installments of June 21, 2018, 2019, 2021, and 2022.

Read SEC document
June 21, 2017 Filed Jun 24, 2017 01:35 UTC
Otten William RobertExecutive VP of Sales
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-17-041359 · a4.xml · nonDerivative · entry 1

Otten William Robert · CIK 0001704840 · Executive VP of Sales

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Read SEC document
June 20, 2017 Filed Jun 21, 2017 22:37 UTC SaleCommon Stock 21,000 $51.86 $1,089,154.50
Disclosure

SEC source: 0001140361-17-025728 · doc1.xml · nonDerivative · entry 2

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,279,007

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.74 to $51.97, inclusive.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document
June 20, 2017 Filed Jun 21, 2017 22:35 UTC
Medici FrankDirector
SaleCommon Stock 21,000 $51.86 $1,089,154.50
Disclosure

SEC source: 0001140361-17-025727 · doc1.xml · nonDerivative · entry 2

Medici Frank · CIK 0001614857 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,279,007

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.74 to $51.97, inclusive.

F2 · ownership.nature: These securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital") is the general partner of Berkley Investors. The reporting person is President of Berkley Capital and as such holds the sole voting and dispositive power over the shares held by Berkley Investors. The reporting person disclaims beneficial ownership of the securities held by Berkley Investors and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purposes.

Read SEC document
June 19, 2017 Filed Jun 21, 2017 22:37 UTC SaleCommon Stock 4,002 $51.99 $208,052.77
Disclosure

SEC source: 0001140361-17-025728 · doc1.xml · nonDerivative · entry 1

Berkley Capital, LLC · CIK 0001614953 · 10% owner

Berkley Capital Investors, L.P. · CIK 0001614951 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 8,300,007

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.53 to $52.14, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.

F2 · ownership.nature: All securities are held of record by Berkley Capital Investors, L.P., a Delaware limited partnership ("Berkley Investors"). Berkley Capital, LLC, a Delaware limited liability company ("Berkley Capital"), is the general partner of Berkley Investors and as such all securities held by Berkley Investors may be deemed attributable to Berkley Capital. The foregoing is not an admission by Berkley Capital that it is the beneficial owner of the securities held of record by Berkley Investors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.